Plasma protein thiols: An early marker of oxidative stress in asthma and chronic obstructive pulmonary disease

European Journal of Clinical Investigation

Volumn 46, Issue 2, 2016, Pages 181-188

  Zinellu, Angelo ^a   Fois, Alessandro Giuseppe ^a   Sotgia, Salvatore ^a   Zinellu, Elisabetta ^a   Bifulco, Fabiana ^a   Pintus, Gianfranco ^a   Mangoni, Arduino A ^b   Carru, Ciriaco ^a   Pirina, Pietro ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Asthma; COPD; Early marker; Oxidative stress; Proteins SH

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUTATHIONE; PROTEIN SULFHYDRYL; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP; THIONEINE; UNCLASSIFIED DRUG; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; PON1 PROTEIN, HUMAN; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL MODEL; VERY ELDERLY; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; ASTHMA; BIOMARKERS; ERGOTHIONEINE; FEMALE; FORCED EXPIRATORY VOLUME; GLUTATHIONE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SULFHYDRYL COMPOUNDS; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAL CAPACITY;

EID: 84953432036     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12582     Document Type: Article

References (41)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
2. Warrier MR, Hershey GK. Asthma genetics: personalizing medicine. J Asthma 2008;45:257-64.
3. Ahmad A, Shameem M, Husain Q. Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med 2012;7:226-32.
4. Nadeem A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003;111:72-8.
5. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-7.
6. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162:701-6.
7. Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001;95:649-54.
8. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
9. Jarjour NN, Calhoun WJ. Enhanced production of oxygen radicals in asthma. J Lab Clin Med 1994;123:131-6.
10. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999;354:482-3.
11. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005;60:293-300.
12. Misso NL, Brooks-Wildhaber J, Ray S, Vally H, Thompson PJ. Plasma concentrations of dietary and non-dietary antioxidants are low in severe asthma. Eur Respir J 2005;26:257-64.
13. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515-48.
14. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001;23:268-87.
15. Rautalahti M, Virtamo J, Haukka J, Heinonen OP, Sundvall J, Albanes D et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med 1997;156:1447-52.
16. Rossi R, Giustarini D, Milzani A, Dalle-Donne I. Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 2009;13:3131-40.
17. Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'byrne P et al. GINA guidelines on asthma and beyond. Allergy 2007;62:102-12.
18. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
19. Rossi R, Dalle-Donne I, Milzani A, Giustarini D. Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clin Chem 2006;52:1406-14.
20. Askari A, Melville DB. The reaction sequence in ergothioneine biosynthesis: hercynine as an intermediate. J Biol Chem 1962;237:1615-8.
21. Paul BD, Snyder SH. The unusual amino acid l-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 2010;17:1134-40.
22. Zinellu A, Sotgia S, Loriga G, Deiana L, Satta AE, Carru C. Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy. Amino Acids 2012;43:1499-507.
23. Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F The important role of taurine in oxidative metabolism. Adv Exp Med Biol 2006;583:129-35.
24. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La DuBN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-90.
25. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366:43-58.
26. Sotgia S, Pisanu E, Pintus G, Erre GL, Pinna GA, Deiana L et al. Plasma l-ergothioneine measurement by high-performance liquid chromatography and capillary electrophoresis after a pre-column derivatization with 5-iodoacetamidofluorescein (5-IAF) and fluorescence detection. PLoS One 2013;8:e70374.
27. Zinellu A, Sotgia S, Scanu B, Chessa R, Gaspa L, Franconi F et al. Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications. Amino Acids 2009;36:35-41.
28. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-21.
29. Gan KN, Smolen A, Eckerson HW, La DuBN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-6.
30. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
31. Rasmussen JL, Dunlap WP. Dealing with nonnormal data: parametric analysis of transformed data vs nonparametric analysis. Educ Psychol Meas 1991;51:809-20.
32. Wise RA, Tashkin DP. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient? Am J Med 2007;120:14-22.
33. Decramer M, Selroos O. Asthma and COPD: differences and similarities. Int J Clin Pract 2005;59:385-98.
34. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M et al. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005;60:834-41.
35. Hoppeler H, Vogt M, Weibel ER, Fluk M. Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 2003;881:109-19.
36. Holguin F. Oxidative stress in airway diseases. Ann Am Thorac Soc 2013;10:150-7.
37. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996;154:1055-60.
38. Sarioglu N, Hismiogullari AA, Erel F, Demir D, Gencer N. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients. Iran J Allergy Asthma Immunol 2015;14:60-6.
39. Harms CA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol 2006;151:124-31.
40. McEvoy MA, Schofield PW, Smith WT, Agho K, Mangoni AA, Soiza RL et al. Serum methylarginines and spirometry-measured lung function in older adults. PLoS One 2013;8:e58390.
41. Dröge W, Schipper HM. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007;6:361-70.